Rani Therapeutics Holdings Inc (RANI)
5.25
+0.03
(+0.57%)
USD |
NASDAQ |
May 20, 16:00
5.35
+0.10
(+1.90%)
After-Hours: 20:00
Rani Therapeutics Holdings Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2021 | 0.00% |
| March 31, 2021 | 0.00% |
| December 31, 2020 | 0.00% |
| Date | Value |
|---|---|
| September 30, 2020 | 0.00% |
| June 30, 2020 | -4.52K% |
| March 31, 2020 | -6.45K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-6.45K%
Minimum
Mar 2020
--
Maximum
Sep 2020
-1.83K%
Average
--
Median
Sep 2020
Profit Margin (Quarterly) Benchmarks
| Kodiak Sciences Inc | -- |
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | -14.54K% |
| IGC Pharma Inc | -2.74K% |
| NovaBay Pharmaceuticals Inc | -122.2% |